Abstract
Combination therapy with ampicillin plus ceftriaxone (AMP+CRO) is the first-line therapy for treating severe infections due to Enterococcus faecalis . However, the pharmacokinetic/pharmacodynamic (PK/PD) index linked to the in vivo efficacy of the combination is not yet defined, hindering dose optimization in the clinic.
Funding Information
  • Departamento Administrativo de Ciencia, Tecnologia e Innovacion (785)
  • Sistema General de Regalías de Colombia (2020000100152)
  • Universidad de Antioquia

This publication has 35 references indexed in Scilit: